These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 6782668

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Minimal useful dose of guanfacine in patients with essential hypertension].
    Pérez Olea J, Ortíz N, Soledad Bertoló M, Allel L, Goity C, Quevedo M.
    Rev Med Chil; 1985 May; 113(5):420-4. PubMed ID: 3912882
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Guanfacine (Estulic) in the monotherapy of essential hypertension, grades I and II, according to WHO].
    Mayer K, Lupínek Z, Janousek S, Podrouzková B.
    Cas Lek Cesk; 1984 Oct 26; 123(43):1306-11. PubMed ID: 6391673
    [No Abstract] [Full Text] [Related]

  • 27. [Haemodynamic investigations with the new antihypertensive drug guanfacine (author's transl)].
    Rosenthal J, Schäfer N, Rauh J, Raschig A.
    Dtsch Med Wochenschr; 1980 Nov 28; 105(48):1680-4. PubMed ID: 7002524
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL, Strocchi E, Ambrosioni E, Magnani B.
    Int J Clin Pharmacol Res; 1983 Nov 28; 3(1):35-9. PubMed ID: 6384071
    [Abstract] [Full Text] [Related]

  • 30. Prolactin, renin, growth hormone, lipoproteins and glucose under guanfacine treatment.
    Hauger-Klevene JH, Balossi EC, Scornavacchi JC.
    Cor Vasa; 1987 Nov 28; 29(4 Suppl 1):17-22. PubMed ID: 3119290
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Comparative study of two antihypertensive agents: guanfacine and guanethidine.
    Szám I, Kállay K.
    Br J Clin Pharmacol; 1980 Nov 28; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786
    [Abstract] [Full Text] [Related]

  • 37. Effects of single and multiple doses of guanfacine in essential hypertension.
    Zamboulis C, Reid JL.
    Clin Pharmacol Ther; 1980 Dec 28; 28(6):715-21. PubMed ID: 7002428
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
    Viskoper RJ, Laszt A, Paran E, Ben Ari J, Goren Y, Modan M.
    Neth J Med; 1987 Aug 28; 31(1-2):58-65. PubMed ID: 3309693
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.